Literature DB >> 17523539

Experimental infection of Atlantic salmon Salmo salar pre-smolts by i.p. injection with new Irish and Norwegian salmonid alphavirus (SAV) isolates: a comparative study.

K E Christie1, D A Graham, M F McLoughlin, S Villoing, D Todd, D Knappskog.   

Abstract

Atlantic salmon Salmo salar L. pre-smolts were experimentally infected with 2 different isolates of salmonid alphavirus (SAV): a Subtype 1 isolate from Ireland and a Subtype 3 isolate from Norway. Sequential samples of tissue and blood were collected during a period of 20 wk post injection and subjected to virus isolation from kidney tissue and serum, detection of viral nucleic acid in heart tissue and serum by real-time RT-PCR, detection of specific antibodies by virus neutralisation assay, and histopathological examination. Successful reproduction of pancreas disease (PD) was obtained by intraperitoneal (i.p.) injection of both isolates. No mortality was observed post infection in either group, but typical PD histopathological lesions in heart and pancreas tissue were observed with both isolates. The prevalence and severity of lesions in the pancreas, heart, skeletal muscle and brain were similar in both groups with only subtle differences recorded. Re-isolation of virus from kidney tissue was performed at 7 and 14 d post infection (d p.i.) only and was positive for both test groups at both sampling points. Isolation of virus from sera from both groups was positive at 4 to 14 d p.i., but was negative at later sampling points when antibody production had begun. Virus may be detected only during the acute phase using both methods. Specific neutralising antibodies could be detected for both test groups from Day 21 p.i. until the end of the experiment at 140 d p.i. Peak antibody titres were seen 70 d p.i. Using real-time RT-PCR, pancreas disease virus (PDV)-specific RNA was detected frequently in serum samples up to 14 d p.i. and occasionally thereafter. In contrast, viral RNA could still be detected in the heart tissue of fish from both groups for at least 140 d p.i.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17523539     DOI: 10.3354/dao075013

Source DB:  PubMed          Journal:  Dis Aquat Organ        ISSN: 0177-5103            Impact factor:   1.802


  13 in total

1.  Alpha interferon and not gamma interferon inhibits salmonid alphavirus subtype 3 replication in vitro.

Authors:  Cheng Xu; Tz-Chun Guo; Stephen Mutoloki; Øyvind Haugland; Inderjit S Marjara; Øystein Evensen
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

2.  Development of infectious cDNA clones of Salmonid alphavirus subtype 3.

Authors:  Marius Karlsen; Stephane Villoing; Karl F Ottem; Espen Rimstad; Are Nylund
Journal:  BMC Res Notes       Date:  2010-09-21

3.  No influence of oxygen levels on pathogenesis and virus shedding in Salmonid alphavirus (SAV)-challenged Atlantic salmon (Salmo salar L.).

Authors:  Linda Andersen; Kjartan Hodneland; Are Nylund
Journal:  Virol J       Date:  2010-08-21       Impact factor: 4.099

4.  The effects of heart and skeletal muscle inflammation and cardiomyopathy syndrome on creatine kinase and lactate dehydrogenase levels in Atlantic salmon (Salmo salar L.).

Authors:  Muhammad Naveed Yousaf; Mark D Powell
Journal:  ScientificWorldJournal       Date:  2012-05-22

5.  Relationship between viral dose and outcome of infection in Atlantic salmon, Salmo salar L., post-smolts bath-challenged with salmonid alphavirus subtype 3.

Authors:  Jiraporn Jarungsriapisit; Lindsey J Moore; Stig Mæhle; Cecilie Skår; Ann Cathrine Einen; Ingrid Uglenes Fiksdal; Hugh Craig Morton; Sigurd O Stefansson; Geir Lasse Taranger; Sonal Patel
Journal:  Vet Res       Date:  2016-10-19       Impact factor: 3.683

6.  Vaccine Adjuvants in Fish Vaccines Make a Difference: Comparing Three Adjuvants (Montanide ISA763A Oil, CpG/Poly I:C Combo and VHSV Glycoprotein) Alone or in Combination Formulated with an Inactivated Whole Salmonid Alphavirus Antigen.

Authors:  Hanna L Thim; Stéphane Villoing; Marian McLoughlin; Karen Elina Christie; Søren Grove; Petter Frost; Jorunn B Jørgensen
Journal:  Vaccines (Basel)       Date:  2014-03-25

7.  The serum proteome of Atlantic salmon, Salmo salar, during pancreas disease (PD) following infection with salmonid alphavirus subtype 3 (SAV3).

Authors:  M Braceland; R Bickerdike; J Tinsley; D Cockerill; M F Mcloughlin; D A Graham; R J Burchmore; W Weir; C Wallace; P D Eckersall
Journal:  J Proteomics       Date:  2013-10-18       Impact factor: 4.044

8.  Atlantic salmon (Salmo salar L.) post-smolts challenged two or nine weeks after seawater-transfer show differences in their susceptibility to salmonid alphavirus subtype 3 (SAV3).

Authors:  J Jarungsriapisit; L J Moore; G L Taranger; T O Nilsen; H C Morton; I U Fiksdal; S Stefansson; P G Fjelldal; Ø Evensen; S Patel
Journal:  Virol J       Date:  2016-04-11       Impact factor: 4.099

9.  Pathogenesis of experimental salmonid alphavirus infection in vivo: an ultrastructural insight.

Authors:  Tharangani K Herath; Hugh W Ferguson; Manfred W Weidmann; James E Bron; Kimberly D Thompson; Alexandra Adams; Katherine F Muir; Randolph H Richards
Journal:  Vet Res       Date:  2016-01-08       Impact factor: 3.683

10.  Rainbow trout (Oncorhynchus mykiss) muscle satellite cells are targets of salmonid alphavirus infection.

Authors:  Stéphane Biacchesi; Grégory Jouvion; Emilie Mérour; Abdelhak Boukadiri; Marion Desdouits; Simona Ozden; Michel Huerre; Pierre-Emmanuel Ceccaldi; Michel Brémont
Journal:  Vet Res       Date:  2016-01-08       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.